TVAR live edited broadcasts are safe.

Original title: The impact of live transmition on patients outcomes during transcatheter aortic valve replacement: Results fron the VERITAS study. Reference: Ron Waskman, et al. Cardiovascular Revascularization Medicine 2014;15:63-68

 

With the advancement of medical technology and the great development of telecommunications, performing live or edited cases has become a common occurrence in medical education, but one of the points of discussion was always the safety of these procedures. This is a multicentre, retrospective observational case-control study. The endpoint of this analysis was the safety of patients receiving percutaneous aortic valve replacement (TVAR) during live broadcasts. Valves used were, for femoral access CoreValve and for femoral or apical access, Edwards SAPIEN. Patients receiving TVAR during a live broadcast were compared with a control group using the following criteria; STS ± 2 points, day of the procedure ±4 weeks, same first surgeon and the same access resulting one control group of 46 patients and live stream group of 46 patients. The safety endpoint was evaluated by the rate of major complications: hospital death, stroke, tamponade, embolization, coronary obstruction, renal failure requiring dialysis and need for pacemaker.

No clinical or echocardiographic results from the group live stream versus the control group were observed. The total duration of the procedure was higher in the live broadcast group (129 ± 49 versus 100 ± 42 minutes p = 0.007) but no difference in fluoroscopy time, number of surgeons, intra procedural complications, stay in coronary unit or hospital. The presence of moderate or severe aortic regurgitation was 4.7 % in the live stream group and 9.5 % in the control group without reaching statistical significance. There were no differences in the safety endpoint, death (2.2 % in each group), conversion to surgery, vascular complications, bleeding, arrhythmias, need for pacemaker or dialysis infections.

Conclusion

These data provide support that procedures of percutaneous aortic valve replacement live broadcast for congress made

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...